Phase composition and in-vitro bioactivity of plasma sprayed calcia stabilized zirconia coatings

Zirconia coatings stabilized with different calcia content (12.8 mol%, 16 mol% and 30 mol%) were fabricated on titanium alloy substrates using atmospheric plasma spraying technology. The in-vitro bioactivity of coatings was evaluated by simulated body fluid (SBF) soaking test. The morphology and phase composition of the coatings were characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM), micro Raman spectroscopy, energy dispersive spectrometry (EDS) and infrared spectroscopy (IR). The results showed that the apatite was formed on the surface of the calcia stabilized zirconia coatings soaked in SBF for 28 days and the formation ability of apatite decreased with the increase in calcia content of the coating. The bioactivity of zirconia coatings was thought to be related to the Zr–OH formed on their surfaces during the phase transformation in the presence of water. Osteoblast-like MG63 cells were cultured on the surfaces of the coatings to evaluate their cytocompatibility. Results showed that MG63 cell grew and proliferated well on all coating surfaces, indicating that plasma sprayed calcia stabilized ZrO2 coatings were cytocompatible.